Patents/Assignees

Regen Biopharma, Inc.

2 patents in portfolio

US11712474utility2023
Reduction of Post-surgery Cancer Metastasis by Combination of Cannabidiol and NR2F6 Inhibition
0 cites
US11655474utility2023
Suppression of Pathological Angiogenesis by Inhibition of NR2F6
0 cites